セロトニン-2A GPCRにおける機能的選択性メカニズムは,細胞内ループ2のリガンド依存型構成を含む
Jose Manuel Perez-Aguilar1, Jufang Shan, Michael V LeVine
1Department of Physiology and Biophysics and §The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University , New York, New York 10065, United States.
Journal of the American Chemical Society
|October 15, 2014
まとめ
分子動力学シミュレーションは,幻覚誘発性アゴニストと非幻覚誘発性アゴニストとの結合時に,セロトニン2A受容体 (5-HT(2A) R) の明確な構造変化を明らかにします. これらの違い,特に細胞内ループ2の違いは,機能的選択性と異なる精神活性効果を説明する可能性がある.
科学分野:
- 構造生物学 構造生物学とは
- コンピューティング・ケミストリー
- 薬理学 薬理学とは
背景:
- Gタンパク質結合受容体 (GPCRs) は重要な薬物の標的であり,その構成状態を理解することは薬剤開発の鍵です.
- 構造生物学と生体物理学の技術の最近の進歩は,GPCRsの詳細な特徴づけを可能にします.
- 分子ダイナミクス (MD) シミュレーションは,GPCRsのダイナミックな構成変化を研究するための強力な計算アプローチを提供します.
研究 の 目的:
- 異なるアゴニストと結合した時のヒトセロトニン2A受容体 (5-HT(2A) R) の動的構成的差異を調査する.
- 5-HT2A) Rリガンドの機能的選択性および異なる薬理学的結果 (幻覚誘発性と非幻覚誘発性) の構造的根拠を解明する.
- 細胞内ループ2 (ICL2) のような特定の受容体領域が,リガンド依存活性化を媒介する役割を調査する.
主な方法:
- 5-HT(2A) R.の偏らないマイクロ秒長全原子分子動力学 (MD) シミュレーションを実行しました.
- アポ (リガンドフリー) 状態の受容体をシミュレートし,既知の異なる薬理学的プロファイルを持つ4つの異なるセロトナーギーアゴニストと結合しました.
- 分析されたシミュレーション経路は,差異性リガンド結合コンタクトと形状の変化を特定します.
主要な成果:
- 幻覚誘発性および非幻覚誘発性リガンドと相互作用する際に,5-HT(2A) Rの明確な構造的および動的差異を特定しました.
- 細胞内回路2 (ICL2) のユニークな形状と相関する,観察された差異性リガンド結合コンタクト.
- これらのICL2構成の変化は,受容体二分化および/またはエフェクタタンパク質との直接相互作用に影響を与え,機能的選択性のメカニズムを示唆すると提案されています.
結論:
- この研究は,5-HT(2A) R.におけるリガンド特異的構成異質性に関する証拠を提供している.
- 細胞内ループ2 (ICL2) は,受容体活性化を微調整し,機能的結果を区別する重要な領域として出現します.
- 発見は,幻覚生成とGPCRの機能的選択性の基礎にある分子機構の洞察を提供します.
関連する概念動画
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K
Dose-Response Relationship: Selectivity and Specificity
10.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.1K
Transducer Mechanism: G Protein–Coupled Receptors
8.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.4K
Selectins
3.6K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.6K
G-protein Coupled Receptors
90.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
90.7K


